Cargando…

OR19-03 Effects of Nonpeptide Orally Bioavailable ACTH Antagonists on Adrenal Gland Size and Function in Rats

Cushing’s disease (CD) and Ectopic ACTH syndrome (EAS) stem from excess circulating adrenocorticotropic hormone (ACTH) and resulting hypercortisolemia. In CD, excess ACTH is secreted from pituitary tumors, whereas excess ACTH in EAS arises from nonpituitary tumors. ACTH acts on the adrenal melanocor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markison, Stacy, Fowler, Melissa A, Athanacio, Jon, Kredel, Taylor A, Antwan, Agnes, Johns, Michael, Tsivkovski, Oleg, Cruz, Shirley, Luo, Rosa, Reinhart, Greg, Kusnetzow, Ana Karin, Madan, Ajay, Betz, Stephen F, Struthers, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209714/ http://dx.doi.org/10.1210/jendso/bvaa046.699

Ejemplares similares

Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess
por: Fowler, Melissa A, et al.
Publicado: (2021)

SAT-364 Nonpeptide Orally-Bioavailable ACTH Antagonists: Suppression of ACTH-Induced Corticosterone Secretion and Adrenal Hypertrophy in Rats
por: Kusnetzow, Ana, et al.
Publicado: (2019)

MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia
por: Kusnetzow, Ana Karin, et al.
Publicado: (2020)

MON-089 Discovery and Identification of Late Stage Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists for the Treatment of Hyperinsulinemic Hypoglycemia
por: Fowler, Melissa A, et al.
Publicado: (2020)

OR12-2 Inhibition of Basal and ACTH-stimulated Cortisol Secretion in Humans Using an Oral Nonpeptide ACTH Antagonist (CRN04894)
por: Betz, Stephen, et al.
Publicado: (2022)

SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019)

SAT-260 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Induced Insulin Secretion in Pancreatic Islets from both Rats and Healthy Human Donors
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2019)

SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023)

OR03-03 New Insights into the Functional Human Adrenal Cortex Zonation
por: Camponova, Paméla, et al.
Publicado: (2020)

LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022)

Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
por: Madan, Ajay, et al.
Publicado: (2022)

ACTH-Dependent Cushing’s Syndrome in an Elderly Woman with Pituitary, Adrenal, and Intrathoracic Lesions
por: Japp, Emily A, et al.
Publicado: (2021)

SUN-197 Giant Adrenal Myelolipoma Associated with Prolonged ACTH Elevation in a Patient with Congenital Adrenal Hyperplasia (CAH)
por: Kaluarachchi, Vidumini, et al.
Publicado: (2020)

Immunohistochemically ACTH positivity in an adrenal adenoma that mimicks pheochromocytoma in terms of clinical and radiological findings
por: Haydardedeoglu, Filiz E, et al.
Publicado: (2023)

FRI538 Discovery And Characterization Of Orally Bioavailable Nonpeptide Thyroid Stimulating Hormone Receptor (TSHR) Antagonists For The Treatment Of Graves’ Disease
por: Fowler, Melissa A, et al.
Publicado: (2023)

MON-185 ACTH-Derived Peptide Antagonists as an Alternative Treatment Strategy for Congenital Adrenal Hyperplasia
por: Schubert, Tina, et al.
Publicado: (2020)

SAT-429 Final Results from the First in Man Phase 1 Clinical Trial of CRN00808, an Orally Bioavailable sst2-Selective, Nonpeptide Somatostatin Biased Agonist, for the Treatment of Acromegaly: Safety, Pharmacokinetics, Pharmacodynamics, and Midazolam Drug Interaction in Healthy Volunteers
por: Madan, Ajay, et al.
Publicado: (2019)

SUN-187 A Case of Adrenal Mass with Elevated ACTH and Cortisol in a Woman with No Cushingoid Features
por: Rajiyah, Tara, et al.
Publicado: (2020)

LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022)

OR03-02 Identification of a Novel Stem/Progenitor Population of the Adrenal Medulla
por: Santambrogio, Alice, et al.
Publicado: (2020)

PSAT055 ACTH-Dependent or ACTH-Independent: The Importance of a Reliable ACTH Assay in Solving a Case of Cushing Syndrome
por: Duro, Teodor, et al.
Publicado: (2022)

MON-LB035 Adrenal Venous Sampling in the Lateralization of Acth-Independent Cushing Syndrome With Bilateral Adrenal Masses: A Case With a 5-Year Follow-Up
por: Kang, Yu Mi, et al.
Publicado: (2020)

SAT-380 Screening for Central Adrenal Insufficiency in Children with Prader-Willi Syndrome (PWS) with Single Collection Of ACTH and Cortisol Levels
por: Angulo, Moris, et al.
Publicado: (2019)

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
por: Zhao, Jian, et al.
Publicado: (2022)

OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
por: Olmos, Roberto Ignacio, et al.
Publicado: (2020)

Severe Cushing Syndrome Due to Ectopic ACTH Secretion by Pheochromocytoma
por: Giorgi, Rafael Buck, et al.
Publicado: (2021)

PSAT054 Isolated ACTH Deficiency in a Patient on Epoprostenol
por: Riordan, Marianne, et al.
Publicado: (2022)

OR25-03 The Effects of Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, on Adrenal Androgens and Precursors in Patients with Classic Congenital Adrenal Hyperplasia: Results from A Multiple-Dose Phase 2 Study
por: Auchus, Richard J, et al.
Publicado: (2020)

SUN-168 Case Series of ACTH-Secreting Pheochromocytoma: Diagnosis and Management
por: Tran, Anh, et al.
Publicado: (2020)

Presentation of ACTH Independent Cushing’s as Severe Insulin Resistance During Pregnancy
por: Faisal, Sobia, et al.
Publicado: (2021)

MON-361 Isolated ACTH Deficiency after Treatment with Immune-Checkpoint Inhibitors
por: O'Hare, James, et al.
Publicado: (2019)

SUN-393 ACTH-secreting Pheochromocytoma - A Rare Cause of Cushing’s Syndrome
por: Pujals Kury, Jean, et al.
Publicado: (2019)

SUN-385 A Rare Case of Ectopic ACTH Secretion by Pancreatic Adenocarcinoma
por: Angela, Le, et al.
Publicado: (2019)

SAT-204 ACTH-Producing Pheochromocytoma, a Challenging Disease to Diagnose and Manage
por: Ferrari, Aldo De, et al.
Publicado: (2020)

MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)

ODP047 Intramuscular ACTH stimulation test in a patient with liver disease
por: Khurram, Daniyeh, et al.
Publicado: (2022)

SUN-387 ACTH-Independent Cushing Syndrome from Pregnancy-Induced Micronodular Hyperplasia
por: Affinati, Alison, et al.
Publicado: (2019)

A Re-Examination of the oCRH Stimulation Test for the Diagnosis of Ectopic ACTH Secretion
por: Newman, Andrew Joseph, et al.
Publicado: (2021)

SAT-213 Parotid Carcinoma Ex Pleomorphic Adenoma Can Produce Ectopic ACTH Too
por: Adly, Hussein, et al.
Publicado: (2020)

SUN-198 Metastatic Progression of Adrenocortical Carcinoma: Phenotypic Transformation to ACTH-Independent Cushing’s Syndrome
por: Ocampo, Javier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ka46ar0errdhj8mbq09lh365kq